• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
APA
Click for more information
0.81% $2.46

Smartshares Asia Pacific ETF Units

watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
APA
Ann: APA NTA 03-10-2024 $2.47265 		07:36 0 22
07:36 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  22 
APA
Ann: APA NTA 02-10-2024 $2.46162 		03/10/24 0 34
03/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  34 
APA
Ann: APA NTA 01-10-2024 $2.43966 		02/10/24 0 34
Metals & Mining SECTOR NEWS

Dive into Bécancour: watch the latest project updates from Lithium Universe

Read More   right-arrow Created with Sketch.
LU7
04 Oct 2024
LITHIUM UNIVERSE LIMITED
02/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  34 
APA
Ann: APA NTA 30-09-2024 $2.43831 		01/10/24 0 37
01/10/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  37 
APA
Ann: APA NTA 27-09-2024 $2.49449 		30/09/24 0 49
30/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  49 
APA
Ann: APA NTA 26-09-2024 $2.42587 		27/09/24 0 37
27/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  37 
APA
Ann: APA NTA 25-09-2024 $2.43896 		26/09/24 0 59
26/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  59 
APA
Ann: APA NTA 24-09-2024 $2.45611 		25/09/24 0 67
25/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  67 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Regulatory approval granted for drilling at high-grade lead and silver project—drilling set to begin soon
right-arrow Created with Sketch.
NEWS High-grade drill results confirm extension at Paddy’s Lodes—reinforcing significant discovery and growth potential at Youanmi Gold Project
right-arrow Created with Sketch.
NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
NEWS Antler Copper Project hits major permitting milestone – air quality permit advances to final review
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
(20min delay)
Last
$2.46 		Change
-0.020(0.81%) 		Mkt cap ! n/a
Open High Low Value Volume
$2.48 $2.48 $2.46 $34.55K 13.96K

Buyers (Bids)

No. Vol. Price($)
0 9 $2.44
 

Sellers (Offers)

Price($) Vol. No.
$2.50 715 0
Last trade - 11.00am 04/10/2024 (20 minute delay) ?
APA (NZSX) Chart

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

BCI Minerals Ltd has achieved financial close on a Syndicated Facility Agreement worth $981 million for its Mardie project in WA
Cokal upgrades infrastructure for BBM ramp-up in Indonesia Cokal Ltd has signed an agreement to facilitate greater haulage capacity from its BBM mine in Indonesia, and boosted bridge infrastructure
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.

Featured News

NEWS $25M secured to fuel growth, see which company is making big moves
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS High-grade copper assays continue to impress—resource update coming soon
right-arrow Created with Sketch.
NEWS Antler Copper Project hits major permitting milestone – air quality permit advances to final review
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.